Lipocine Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Lipocine Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2012 to Q3 2024.
  • Lipocine Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 5.35M shares, a 1.06% increase year-over-year.
  • Lipocine Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 5.27M shares, a 0.26% increase from 2022.
  • Lipocine Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 5.26M shares, a 94% decline from 2021.
  • Lipocine Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 87.6M shares, a 57.3% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 5.35M +55.9K +1.06% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 5.34M +109K +2.08% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 5.36M +123K +2.34% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 5.27M +13.5K +0.26% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 5.29M +41.9K +0.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 5.23M -28.6K -0.54% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 5.23M -83.1M -94.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 5.26M -82.4M -94% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 5.25M -83.7M -94.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 5.26M -83.7M -94.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 88.3M +6.43M +7.85% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 87.6M +31.9M +57.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 89M +24.1M +37.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 89M +39.2M +78.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 81.9M +40.5M +98% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 55.7M +29.8M +115% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-09
Q3 2020 64.8M +39.9M +160% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 49.8M +25.2M +102% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 41.3M +18M +76.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 25.9M +4.53M +21.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 24.9M +3.65M +17.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 24.6M +3.33M +15.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 23.4M +2.12M +9.96% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 21.4M +1.3M +6.49% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 21.3M +376K +1.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 21.3M +1.89M +9.77% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 21.3M +2.55M +13.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 20.1M +1.79M +9.83% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 20.9M +2.64M +14.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 19.4M +1.12M +6.14% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 18.7M +459K +2.52% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q4 2016 18.3M +1.79M +10.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-06
Q3 2016 18.3M +14K +0.08% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 18.3M +1.76M +10.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 18.3M +5.43M +42.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 16.5M +3.7M +29% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 18.2M +5.46M +42.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 16.5M +3.73M +29.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 12.8M +91.2K +0.72% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 12.8M +5.4M +73.4% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-06
Q3 2014 12.8M +3.86M +43.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 12.8M +8.31M +187% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 12.7M +8.27M +186% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 7.36M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-11
Q3 2013 8.91M +4.46M +100% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 4.46M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 4.46M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q3 2012 4.46M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.